<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137882">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01306149</url>
  </required_header>
  <id_info>
    <org_study_id>FWO01-03-21</org_study_id>
    <nct_id>NCT01306149</nct_id>
  </id_info>
  <brief_title>Natural History of Mineral Metabolism Parameters and Protein-bound Toxins in Incident Peritoneal Dialysis Patients</brief_title>
  <official_title>Natural History of Biochemical Parameters of Mineral Metabolism and Protein-bound Uremic Retention Molecules in Incident Peritoneal Dialysis Patients: a Longitudinal Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this study are

        1. To evaluate the natural history of plasma concentrations and renal and peritoneal
           clearances of small water-soluble uremic retention molecules (URM), 'middle molecules',
           and protein bound URM in incident peritoneal dialysis (PD) patients.

        2. To evaluate the natural history and determinants of the generation rate of URM
           originating from bacterial protein fermentation in PD patients.

        3. To evaluate the natural history of biochemical parameters of mineral metabolism in
           incident PD patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2002</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>natural history of clearances and serum parameters of mineral metabolism and protein-bound toxins</measure>
    <time_frame>15 years</time_frame>
    <description>To evaluate the natural history of plasma concentrations and renal and peritoneal clearances of small water-soluble uremic retention molecules (URM), 'middle molecules, and protein bound URM in incident peritoneal dialysis (PD) patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>determinants of generation rate of uremic retention solutes</measure>
    <time_frame>15 years on average</time_frame>
    <description>To evaluate the natural history and determinants of the generation rate of URM originating from bacterial protein fermentation in PD patients.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Complication of Peritoneal Dialysis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, urine and dialysate
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Incident peritoneal dialysis patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Incident PD patients, defined as patients who started on PD as first renal
             replacement therapy less than 8 weeks before inclusion

          -  written informed consent

          -  age &gt; 18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pieter Evenepoel, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Leuven, Belgium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pieter Evenepoel, MD,PhD</last_name>
    <phone>003216344580</phone>
    <email>pieter.evenepoel@uz.kuleuven.ac.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pieter Evenepoel, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <lastchanged_date>December 2, 2014</lastchanged_date>
  <firstreceived_date>February 23, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Bj√∂rn Meijers</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>biochemical parameters</keyword>
  <keyword>mineral metabolism</keyword>
  <keyword>protein-bound uremic retention solutes</keyword>
  <keyword>incident PD patients</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
